Product fact sheet
NOW Beta-Glucans + ImmunEnhancer: Yeast Glucan vs Oat Beta-Glucan
Evidence-aware review of NOW Beta-Glucans with ImmunEnhancer Extra Strength, explaining its 500 mg yeast beta-1,3/1,6-glucan and 400 mg larch arabinogalactan doses and why oat-beta-glucan evidence does not transfer.
A useful anti-confusion comparator rather than a conventional prebiotic powder: two capsules provide 500 mg yeast beta-1,3/1,6-glucan plus 400 mg larch arabinogalactan. Those structures and doses are fundamentally different from 3 g oat beta-glucan or 15 g ResistAid microbiome studies, so the word beta-glucan must not collapse them into one evidence bucket.
Shoppers trying to understand yeast beta-glucan versus cereal beta-glucan, People comparing low-dose immune-oriented larch arabinogalactan with gram-dose prebiotic powders
Anyone seeking the 3 g/day oat beta-glucan dose used for cholesterol lowering, Anyone seeking a gram-dose arabinogalactan intervention comparable to the 15 g/day microbiome trial
Key tradeoff: Clear label and useful structural comparator, but its immune-oriented sub-gram ingredients should not borrow the clinical story of cereal beta-glucan or high-dose larch-fiber trials.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
NOW Beta-Glucans with ImmunEnhancer Extra Strength is useful on Homeapotherapy primarily because it exposes a common comparison error.
Two capsules provide 500 mg beta-1,3/1,6-D-glucan from Saccharomyces cerevisiae plus 400 mg larch arabinogalactan. Both ingredients can appear in conversations about immunity, microbiota and “prebiotics,” but their structure and dose are very different from the fibers used in the strongest oat and larch trials.
Yeast beta-glucan is not oat beta-glucan
The cholesterol literature for beta-glucan largely concerns oat/barley beta-1,3/1,4-glucan at gram doses. A meta-analysis of randomized trials found cholesterol lowering with at least 3 g/day oat beta-glucan.
This NOW formula instead provides 0.5 g of yeast beta-1,3/1,6-glucan. That is a different molecular linkage pattern, source, physical behavior and intended use.
The correct conclusion is not that one is stronger than the other. It is that they answer different evidence questions.
The larch dose is also much smaller than microbiome protocols
The formula contains 400 mg larch arabinogalactan per two capsules.
A modern randomized microbiome trial of the branded larch ingredient ResistAid used 15 g/day—more than 37 times the arabinogalactan amount in this NOW serving. The trial changed microbiome composition but did not significantly improve bowel habits or GI symptoms.
A separate immune-response trial used 1.5 or 4.5 g/day ResistAid, still several-fold above the 400 mg amount here.
Those studies provide ingredient context; they do not validate this finished combination.
Current label snapshot
| Feature | Amount per 2 capsules |
|---|---|
| Yeast beta-1,3/1,6-D-glucan | 500 mg |
| Larch arabinogalactan / ImmunEnhancer | 400 mg |
| Product role | Immune-support combination |
Why this belongs beside prebiotic products
Consumers routinely see “beta-glucan,” “arabinogalactan,” “immune support” and “prebiotic” used in overlapping marketing. A useful evidence catalog should therefore show the non-equivalence rather than hide products in separate silos.
For bowel-function or cholesterol decisions, compare the actual substrate and gram dose first. For an immune-oriented product, evaluate immune endpoints separately instead of borrowing evidence from cereal-fiber or high-dose microbiome studies.
See Prebiotics: Best Fiber Types, Doses & Products by Evidence for the structural comparison.
Formula facts
Ingredients, actives and label details
- Yeast beta-glucan
- 500 mg beta-1,3/1,6-D-glucan from Saccharomyces cerevisiae per 2 capsules Basis: Manufacturer Source: Beta-Glucans with ImmunEnhancer Extra Strength — official product information
- Larch arabinogalactan
- 400 mg ImmunEnhancer arabinogalactan from Larix laricina per 2 capsules Basis: Manufacturer Source: Beta-Glucans with ImmunEnhancer Extra Strength — official product information
- Why oat evidence does not transfer
- Oat cholesterol meta-analysis evaluated ≥3 g/day cereal beta-glucan, a different linkage structure and much larger fiber dose than 500 mg yeast beta-1,3/1,6-glucan Basis: Systematic review Source: Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials
- Arabinogalactan dose gap
- 400 mg per serving versus 15 g/day in a randomized ResistAid microbiome trial Basis: Randomized trial Source: Effect of arabinogalactan on the gut microbiome: a randomized, double-blind, placebo-controlled, crossover trial in healthy adults
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- Beta-Glucans with ImmunEnhancer Extra Strength — official product informationNOW Foods · Manufacturer · retrieved 2026-08-12
- Effect of arabinogalactan on the gut microbiome: a randomized, double-blind, placebo-controlled, crossover trial in healthy adultsNutrition · Professional health · retrieved 2026-08-12
- Immunomodulatory effects of ResistAid: a randomized, double-blind, placebo-controlled, multidose studyJournal of the American College of Nutrition · Professional health · retrieved 2026-08-12
- Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trialsAmerican Journal of Clinical Nutrition · Systematic review · retrieved 2026-08-12